Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Operating Margin (2016 - 2025)

Nephros (NEPH) has 16 years of Operating Margin data on record, last reported at 6.59% in Q3 2025.

  • For Q3 2025, Operating Margin rose 74.0% year-over-year to 6.59%; the TTM value through Sep 2025 reached 8.06%, up 1515.0%, while the annual FY2024 figure was 0.04%, 1123.0% up from the prior year.
  • Operating Margin reached 6.59% in Q3 2025 per NEPH's latest filing, up from 5.61% in the prior quarter.
  • Across five years, Operating Margin topped out at 11.61% in Q1 2025 and bottomed at 71.65% in Q1 2022.
  • Average Operating Margin over 5 years is 19.85%, with a median of 12.27% recorded in 2023.
  • Peak YoY movement for Operating Margin: crashed -3445bps in 2022, then skyrocketed 6338bps in 2023.
  • A 5-year view of Operating Margin shows it stood at 27.97% in 2021, then grew by 3bps to 27.09% in 2022, then grew by 26bps to 19.94% in 2023, then skyrocketed by 141bps to 8.19% in 2024, then decreased by -20bps to 6.59% in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Margin were 6.59% in Q3 2025, 5.61% in Q2 2025, and 11.61% in Q1 2025.